EU Drug Agency OKs Rule On Biosimilar Antibodies
The European Union's drug oversight agency on Friday adopted a new guideline governing biosimilar antibody medicines used to treat cancer and autoimmune diseases, moving Europe closer to allowing pharmaceutical makers to...To view the full article, register now.
Already a subscriber? Click here to view full article